MAHBUB, A.A., LE MAITRE, C.L., HAYWOOD-SMALL, S.L., CROSS, N.A. and JORDAN-MAHY, N. (2015). Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines. Cell Death and Disease, 6, e2028. [Article]
Documents
11343:34116
PDF
Mahbub et al - Glutathione is key to the synergistic enhancements of doxorubin.pdf - Published Version
Available under License Creative Commons Attribution.
Mahbub et al - Glutathione is key to the synergistic enhancements of doxorubin.pdf - Published Version
Available under License Creative Commons Attribution.
Download (708kB) | Preview
11343:34128
PDF (Acceptance e-mail)
Jordan-Mahy - 11343.pdf
Restricted to Repository staff only
Jordan-Mahy - 11343.pdf
Restricted to Repository staff only
Download (177kB)
Abstract
Recently published in Nature: Cell Death and Discovery,
Mahbub et al.1 have demonstrated that polyphenols can
synergistically enhance the action of the topoisomerase II
inhibitors: doxorubicin and etoposide in leukaemia cells. A
reduction of glutathione (GSH) was strongly associated with
sensitising cells to the pro-apoptotic effects of polyphenols when used in combination with doxorubicin or etoposide. Importantly, when polyphenols and topoisomerase II inhibitors were combined, it was possible to induce a
synergistic decrease in cell proliferation (measured as ATP
levels), cell-cycle arrest and induction of apoptosis in
leukaemia cell lines.
More Information
Statistics
Downloads
Downloads per month over past year
Metrics
Altmetric Badge
Dimensions Badge
Share
Actions (login required)
View Item |